Establishment Non Current Liabilities Other from 2010 to 2025
| ESTA Stock | USD 35.78 0.57 1.62% |
Non Current Liabilities Other | First Reported 2018-12-31 | Previous Quarter 154 K | Current Value 79 K | Quarterly Volatility 36.3 M |
Check Establishment Labs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Establishment Labs' main balance sheet or income statement drivers, such as Interest Income of 511.2 K, Interest Expense of 9.4 M or Selling General Administrative of 173.3 M, as well as many indicators such as Price To Sales Ratio of 4.38, Dividend Yield of 0.0 or PTB Ratio of 43.51. Establishment financial statements analysis is a perfect complement when working with Establishment Labs Valuation or Volatility modules.
Establishment | Non Current Liabilities Other |
Latest Establishment Labs' Non Current Liabilities Other Growth Pattern
Below is the plot of the Non Current Liabilities Other of Establishment Labs Holdings over the last few years. It is Establishment Labs' Non Current Liabilities Other historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Establishment Labs' overall financial position and show how it may be relating to other accounts over time.
| Non Current Liabilities Other | 10 Years Trend |
|
Non Current Liabilities Other |
| Timeline |
Establishment Non Current Liabilities Other Regression Statistics
| Arithmetic Mean | 12,320,478 | |
| Geometric Mean | 1,340,300 | |
| Coefficient Of Variation | 353.22 | |
| Mean Deviation | 20,392,565 | |
| Median | 1,425,000 | |
| Standard Deviation | 43,518,159 | |
| Sample Variance | 1893.8T | |
| Range | 175.3M | |
| R-Value | 0.24 | |
| Mean Square Error | 1907.5T | |
| R-Squared | 0.06 | |
| Significance | 0.36 | |
| Slope | 2,237,969 | |
| Total Sum of Squares | 28407.5T |
Establishment Non Current Liabilities Other History
About Establishment Labs Financial Statements
Establishment Labs stakeholders use historical fundamental indicators, such as Establishment Labs' Non Current Liabilities Other, to determine how well the company is positioned to perform in the future. Although Establishment Labs investors may analyze each financial statement separately, they are all interrelated. For example, changes in Establishment Labs' assets and liabilities are reflected in the revenues and expenses on Establishment Labs' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Establishment Labs Holdings. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Non Current Liabilities Other | 169.1 K | 160.6 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Establishment Labs offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Establishment Labs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Establishment Labs Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Establishment Labs Holdings Stock:Check out the analysis of Establishment Labs Correlation against competitors. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Establishment Labs. If investors know Establishment will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Establishment Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.59) | Revenue Per Share | Quarterly Revenue Growth 0.045 | Return On Assets | Return On Equity |
The market value of Establishment Labs is measured differently than its book value, which is the value of Establishment that is recorded on the company's balance sheet. Investors also form their own opinion of Establishment Labs' value that differs from its market value or its book value, called intrinsic value, which is Establishment Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Establishment Labs' market value can be influenced by many factors that don't directly affect Establishment Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Establishment Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Establishment Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Establishment Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.